Skip to main content
. 2019 May 14;9(5):e025990. doi: 10.1136/bmjopen-2018-025990

Table 1.

Clinical outcomes during the acute phase of management

All patients* HVI LVI P value
No of patients 207 76 122
LOS, days, median (IQR) 9 (3–18) 14 (4–24) 8 (3–15) <0.001
LOS/TBSA, days/%, median (IQR) 2 (1–4) 3 (1–8) 2 (1–3) <0.001
TBSA, %, median (IQR) 4 (1–10) 3 (1–15) 5 (2–9) 0.44
No of ORs, median (IQR) 1 (0–2) 2 (0–3) 0 (0–1) <0.001
Complications, no (%)
 Rhabdomyolysis 9 (4) 9 (12) 0 (0) <0.001
 Compartment syndrome 17 (8) 12 (16) 5 (4) 0.007
 Infection 28 (14) 15 (20) 11 (9) 0.05
 Sepsis 11 (5) 8 (11) 3 (2) 0.02
 Multiple organ failure 1 (0) 1 (1) 0 (0) 0.38
 Amputation 26 (13) 21 (28) 3 (2) <0.001
 Multiple amputations 13 (6) 10 (13) 2 (2) 0.001
Requiring rehabilitation, no. (%) 106 (51) 49 (64) 54 (44) 0.008
 Discharged to inpatient rehabilitation, no (%)† 34 (32) 22 (45) 10 (19) 0.005
 Discharged to outpatient rehabilitation, no (%)† 72 (68) 27 (55) 44 (81) 0.005
Mortality, no (%) 4 (2) 3 (4) 1 (1) 0.16

*Includes patients whose voltage was not otherwise specified (n=9).

†Percentages are calculated based on the total number of patients requiring any form of rehabilitation (all patients, n=106; HVI, n=49; LVI, n=54).

HVI, high-voltage injury; LOS, length of stay; LVI, low-voltage injury; TBSA, total body surface area.